ArticleNature communications2023

Loss of LCMT1 and biased protein phosphatase 2A heterotrimerization drive prostate cancer progression and therapy resistance.

Reyaz Ur Rasool et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.